| http://www.w3.org/ns/prov#value | - (4) the pharmaceutical composition according to any one of (1) to (3) which has a binding activity to the cannabinoid type 2 receptor wherein R1 is a group represented by the formula: ???Y1???Y2???Y3???Ra wherein Y1, Y2, Y3, Ra, and Rb are as defined in (1),
|
